The collaboration leverages JW Pharmaceutical’s established research and development capabilities to accelerate the drug’s entry into South Korea’s growing metabolic disease sector.
Gan & Lee Pharmaceuticals expands Bofanglutide to South Korea with JW Pharmaceutical partnership
Source: Healthcaremea
Read Full Story →
